Top Stories
-
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
-
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Topic
-
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
-
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
Topic
Latest News
- February 10, 2021
Specialized psychosocial interventions—including meaning-centered psychotherapy—can greatly improve a cancer patient's quality of life and reduce suffering.
Topic
- February 5, 2021
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
Topic
- February 1, 2021
Restoring an enzyme that maintains the way chromosomes are packed inside cells may lead to new therapies for some blood cancers, according to a new study by Columbia researchers.
Topic
- January 29, 2021
The HPV vaccine has great potential to reduce the rate of cervical cancer in Africa, where Columbia researchers are trying to increase vaccination rates with texts.
Topic
- January 11, 2021
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
Topic
- January 11, 2021
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
Topic
- January 11, 2021
A new study has found that up to 20% of aggressive brain cancers are fueled by overactive mitochondria and new drugs in development may be able to starve the cancers.
Topic
- December 23, 2020
A new study conducted at Columbia and other centers found that 80% of patients with a type of slow-growing lymphoma achieved a complete remission with a single infusion of CAR T-cell immunotherapy.
Topic
- December 9, 2020
For multiple myeloma patients with RAS mutations, inhibiting an enzyme involved in cell proliferation may help patients resistant to current therapies, a new Columbia study has found.
- November 27, 2020
Columbia researchers characterized a new class of ‘biomimetic’ drugs that plug a calcium channel implicated in the development of cancer and several other diseases.
Topic
